GC
VRTX icon

Gilbert & Cook’s Vertex Pharmaceuticals VRTX Stock Holding History

Gilbert & Cook’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-784
Closed -$276K – 243
2023
Q2 		$276K Sell
784
-390
-33% -$131K 0.04% 177
2023
Q1 		$370K Buy
1,174
+262
+29% +$78.6K 0.06% 138
2022
Q4 		$263K Buy
912
+7
+0.8% +$2.13K 0.05% 183
2022
Q3 		$281K Buy
+905
New +$260K 0.06% 166
2020
Q4 		– Sell
-1,090
Closed -$297K – 193
2020
Q3 		$297K Buy
1,090
+43
+4% +$11.9K 0.07% 111
2020
Q2 		$304K Sell
1,047
-44
-4% -$11.9K 0.08% 94
2020
Q1 		$260K Buy
1,091
+28
+3% +$6.42K 0.08% 91
2019
Q4 		$233K Buy
+1,063
New +$215K 0.06% 131

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return